IRISBOND Hiru Eye Tracker User Manual
- June 5, 2024
- IRISBOND
Table of Contents
IRISBOND Hiru Eye Tracker User Manual
User Manual IRISBOND Hiru Eye Tracking System
IRISBOND CROWDBONDING, S.L. All rights reserved.
This document, including all supporting materials, is proprietary to IRISBOND CROWDBONDING, S.L.
As this document may contain information that is confidential, proprietary, or otherwise legally protected, it must not be further copied, distributed, or displayed without the express written permission of IRISBOND CROWDBONDING, S.L.
Products that are referred to in this document may be either trademarks and/or registered trademarks of the respective owners. The publisher and the author make no claim to these trademarks.
Contact Information
IRISBOND CROWDBONDING, S.L
Tolosa Avenue 75, 2nd floor
20018 Donostia-San Sebastián, Gipuzkoa, Spain
+34 943 496 622
Windows Eye Control: Microsoft HID Protocol
Install HiruSystray from this link: https://downloads.irisbond.com/systray
The Systray icon will open in the Windows Toolbar.
Open Windows Eye Control
Go to Settings > Ease of Access > Eye Control > Turn on the toggle
Activate HID integration for start using Hiru with Windows Eye Control
Go to Systray and click in Start HID.
Calibrate Hiru by clicking in Show HID Calibration
After calibrating, star controlling the Windows Eye Control bar with Hiru. Stop HID connection if using other apps integrated.
Compliance Information: CE and MDR
DECLARATION OF CONFORMITY
MANUFACTURER| __
IRISBOND CROWDBONDING, SL VAT: ES-B75091058
ADDRESS:
AVENIDA DE TOLOSA, 75 – 2º
San Sebastián CP: 20018
Guipúzcoa, País Vasco
---|---
APPLICABLE DIRECTIVE| COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning
medical devices
HARMONIZED STANDARDS| EN 55032 (2015) / AC (2016) / A11 (2020)
EN 55035 (2017):
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition) ICES-003 Issue 6 (2016)
PRODUCT| Sistema de control del ordenador con la mirada HIRU/ Eye tracking
system HIRU
REFERENCE| IRISBOND HIRU
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
The device model has been designed and manufactured in conformity with
the Directive.
San Sebastián, a 30th of April 2021
Eduardo Jauregui / Technical Director
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL ES-B75091058
AVENIDA DE TOLOSA, 75 – 2º
San Sebastián, 20018 Guipúzcoa, Spain
+34 9434 96 622
---|---
REFERENCE| IRISBOND HIRU
PRODUCT| Eye tracking system HIRU
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonised legislation:
APPLICABLE DIRECTIVE| • Directive (UE) 2017/745 concerning medical devices,
MDR.
• EMC Directive, 2004/108/EC.
• RoHS Directive, 2011/65/EU.
• FCC Rules and Regulations.
---|---
The following harmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION| EN 55032 (2015) / AC (2016) / A11 (2020)
EN 55035 (2017)
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6 (2016)
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in
San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL ES-B75091058
AVENIDA DE TOLOSA, 75 – 2º
San Sebastián, 20018 Guipúzcoa, Spain
+34 9434 96 622
---|---
REFERENCE| OSKOL WINDOWS
PRODUCT| This product is composed by the following elements:
• Medical device; Eye tracking system HIRU.
• Case to bundle the Irisbond HIRU eye tracker and the Surface Pro tablet
(TPU material has PASSED skin sensitization and cytotoxicity tests in
accordance with ISO 10993-5 and 10993-10).
The aim of this declaration is a Class I Medical Device and is in conformity with the following directives:
APPLICABLE DIRECTIVE| REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND
OF THE COUNCIL of 5 April 2017 on medical devices, MRD, amending Directive
2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and
repealing Council Directive 90/385/EEC.
---|---
The following harmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION| HIRU:
EN 55032: 2015 / AC: 2016 / A11: 2020
EN 55035: 2017
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6: 2016
OSKOL Windows:
ISO 10993-5
ISO 10993-10
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
MANUFACTURER| IRISBOND CROWDBONDING, SL ES-B75091058
AVENIDA DE TOLOSA, 75 – 2º
San Sebastián, 20018 Guipúzcoa, Spain
+34 9434 96 622
---|---
REFERENCE| OSKOL iPad
PRODUCT| This product is composed by the following elements:
• Eye tracking system HIRU, medical device class I.
• Case to bundle the Irisbond HIRU eye tracker and the iPad Pro tablet (TPU
material has PASSED skin sensitization and cytotoxicity tests in accordance
with ISO 10993-5 and 10993-10)
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonised legislation:
APPLICABLE DIRECTIVE| REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND
OF THE COUNCIL of 5 April 2017 concerning medical devices, MDR, amending
Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No
1223/2009 and repealing Council Directive 90/385/EEC.
---|---
The following harmonized and/or unharmonized standards and technical specifications have been applied:
HARMONIZED LEGISLATION| HIRU:
EN 55032: 2015 / AC: 2016 / A11: 2020
EN 55035: 2017
UNE-EN 62471-1:2009
FCC CFR 47, Part 15, Subpart B (10-1-15 Edition)
ICES-003 Issue 6: 2016
OSKOL iPad:
ISO 10993-5
ISO 10993-10
---|---
TEST CERTIFICATES| 65321IEM.001
65321REM.001
65321REM.002
2251989-PHO-21-018A
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in
San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Technical Specifications
Optimum screen size | 10-20” |
---|---|
Recommended working distance | 35-80 cm. |
Calibration | 0, 1, 5, 9, 16 points |
Selection mode | Dwell, Blink, Switch |
Head box | 20 x 18 cm. at 50 cm. |
Eye tracking | Monocular and binocular |
Accuracy | 0.4º |
Sampling rate (Frequency) | 60 Hz. |
Mounting
| Holder, magnets, or specific adaptor for consumer device
Operating system| Windows: 7-10 iPadOS: 13 or above Others: Please get in
touch with us
Eye Tracking processing| Hiru on-chip eye tracking technology
Minimum system requirements (laptop, PC, tablet)| Eye-tracking processing done
at HIRU itself. System requirements related to the applications used with
HIRU. Typically:
• USB 3.0 -C
• 1,33 GHz CPU
• 2 GB RAM
• 3GB + HDD Hard Disk
• Intel Graphics, Nvidia and others with OpenGL 2.0
• iOS: iPad Pro
Weight| 115 g.
Dimensions| 259 x 25 x 28 mm.
Eye tracking technology| Dark pupil
USB connector| USB-C
See it Possible
Avenida de Tolosa, 75. Floor 2
Donostia San-Sebastián. 20018 Gipuzkoa
Spain +34 943 49 66 22
References
Read User Manual Online (PDF format)
Read User Manual Online (PDF format) >>